Mould-Quevedo J - Search Results

1

Contributions of cost-effectiveness analyses (CEA) to influenza vaccination policy for older adults in Europe.

Chicoye A, Crépey P, Nguyen VH, Márquez-Peláez S, Postma M, Pugliese A, Ruiz-Aragón J, Mould-Quevedo J. Chicoye A, et al. Among authors: mould quevedo j. Vaccine. 2023 Aug 31;41(38):5518-5524. doi: 10.1016/j.vaccine.2023.07.073. Epub 2023 Aug 5. Vaccine. 2023. PMID: 37550142 Free article. Review.

2

A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.

Divino V, Krishnarajah G, Pelton SI, Mould-Quevedo J, Anupindi VR, DeKoven M, Postma MJ. Divino V, et al. Vaccine. 2020 Sep 11;38(40):6334-6343. doi: 10.1016/j.vaccine.2020.07.023. Epub 2020 Jul 30. Vaccine. 2020. PMID: 32739119 Free article.

3

Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017-2018 Influenza Season.

Pelton SI, Divino V, Shah D, Mould-Quevedo J, DeKoven M, Krishnarajah G, Postma MJ. Pelton SI, et al. Vaccines (Basel). 2020 Aug 7;8(3):446. doi: 10.3390/vaccines8030446. Vaccines (Basel). 2020. PMID: 32784684 Free PMC article.

4

Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018-19 Influenza Season in the United States.

Krishnarajah G, Divino V, Postma MJ, Pelton SI, Anupindi VR, DeKoven M, Mould-Quevedo J. Krishnarajah G, et al. Vaccines (Basel). 2021 Jan 23;9(2):80. doi: 10.3390/vaccines9020080. Vaccines (Basel). 2021. PMID: 33498724 Free PMC article.

5

A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.

Pelton SI, Divino V, Postma MJ, Shah D, Mould-Quevedo J, DeKoven M, Krishnarajah G. Pelton SI, et al. Vaccine. 2021 Apr 22;39(17):2396-2407. doi: 10.1016/j.vaccine.2021.03.054. Epub 2021 Mar 30. Vaccine. 2021. PMID: 33810903 Free article.

6

The Epidemiological and Economic Impact of a Cell-Based Quadrivalent Influenza Vaccine in Adults in the US: A Dynamic Modeling Approach.

Nguyen VH, Hilsky Y, Mould-Quevedo J. Nguyen VH, et al. Vaccines (Basel). 2021 Sep 28;9(10):1095. doi: 10.3390/vaccines9101095. Vaccines (Basel). 2021. PMID: 34696203 Free PMC article.

7

Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019-20 Influenza Season-A Retrospective Cohort Analysis.

Levin MJ, Divino V, Shah D, DeKoven M, Mould-Quevedo J, Pelton SI, Postma MJ. Levin MJ, et al. Vaccines (Basel). 2021 Oct 8;9(10):1146. doi: 10.3390/vaccines9101146. Vaccines (Basel). 2021. PMID: 34696254 Free PMC article.

8

A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019-2020 Influenza Season in the United States.

Divino V, Ruthwik Anupindi V, DeKoven M, Mould-Quevedo J, Pelton SI, Postma MJ, Levin MJ. Divino V, et al. Open Forum Infect Dis. 2021 Dec 4;9(1):ofab604. doi: 10.1093/ofid/ofab604. eCollection 2022 Jan. Open Forum Infect Dis. 2021. PMID: 35028334 Free PMC article.

9

Estimating the Impact of Influenza Vaccination on Acute and ICU Hospital Bed Usage in an Influenza Season under Endemic COVID-19 in the US.

Nguyen VH, Mould-Quevedo JF. Nguyen VH, et al. Vaccines (Basel). 2022 Nov 11;10(11):1908. doi: 10.3390/vaccines10111908. Vaccines (Basel). 2022. PMID: 36423004 Free PMC article.

10

Estimating the impact of influenza vaccination of low-risk 50-64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK.

Nguyen VH, Ashraf M, Mould-Quevedo JF. Nguyen VH, et al. Hum Vaccin Immunother. 2023 Dec 31;19(1):2187592. doi: 10.1080/21645515.2023.2187592. Epub 2023 Mar 13. Hum Vaccin Immunother. 2023. PMID: 36912725 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page